Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 783.20M | £ 1.21B | £ 975.90M | £ 683.60M | £ 299.10M |
Total Assets | £ 9.60B | £ 9.44B | £ 9.07B | £ 8.64B | £ 8.96B |
Total Debt | £ 3.70B | £ 3.81B | £ 4.01B | £ 4.09B | £ 4.10B |
Net Debt | £ 2.91B | £ 2.60B | £ 3.03B | £ 3.41B | £ 3.80B |
Total Liabilities | £ 6.59B | £ 6.53B | £ 6.54B | £ 6.35B | £ 6.25B |
Stockholders Equity | £ 3.01B | £ 2.91B | £ 2.53B | £ 2.28B | £ 2.71B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |